Clinical efficacy of sequential invasive-noninvasive mechanical ventilation for chronic obstructive pulmonary disease complicated by type II respiratory failure / 中国基层医药

ABSTRACT

Objective:To investigate the clinical efficacy of sequential invasive-noninvasive mechanical ventilation for chronic obstructive pulmonary disease complicated by type II respiratory failure.Methods:Eighty-four patients with chronic obstructive pulmonary disease complicated by type II respiratory failure who received treatment in The First Affiliated Hospital of University of Science and Technology of China from January 2017 to December 2019 were included in this study. Patients were selected to withdraw the ventilator for performing a spontaneous breathing test according to recovery status. Patients who underwent invasive mechanical ventilation were included in the control group ( n = 42). Patients who underwent sequential invasive-noninvasive mechanical ventilation based on the pulmonary infection control window were included in the observation group. Mortality rate, reintubation rate, total ventilation time, length of hospital stay, heart rate, and blood gas analysis were compared between the two groups. Results:The length of hospital stay and total ventilation time in the observation group were (9.69 ± 1.94) days and (7.49 ± 1.53) days, respectively, which were significantly shorter than those in the control group ( t = 8.87, 5.10, both P < 0.05). Reintubation rate and mortality rate in the observation group were 4.76% (2/42) and 2.38% (1/42), respectively, which were significantly lower than those in the control group ( χ2 = 5.13, 3.90, both P < 0.05). In each group, heart rate, partial pressure of carbon dioxide and partial pressure of oxygen measured after treatment were superior to those measured before treatment (all P < 0.05). Conclusion:Based on pulmonary infection control window, invasive-noninvasive sequential ventilation for chronic obstructive pulmonary disease complicated by type II respiratory failure can not only reduce total ventilation time and length of hospital stay, remarkably improve clinical manifestations, but also effectively reduce reintubation rate and mortality rate.